Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma. - Wikidata - wikimedia - TriplyDB

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

http://www.wikidata.org/entity/Q34293007

about

Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.PIAS1 Promotes Lymphomagenesis through MYC Upregulation Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal.SUMO and the robustness of cancer.The Role of PIAS SUMO E3-Ligases in Cancer.Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma.Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.Histone deacetylase 7 silencing induces apoptosis and autophagy in salivary mucoepidermoid carcinoma cells.The post-translational modification, SUMOylation, and cancer (Review).Regulation of miR-34b/c-targeted gene expression program by SUMOylation.Streptonigrin Inhibits SENP1 and Reduces the Protein Level of Hypoxia-Inducible Factor 1α (HIF1α) in Cells.

P2860

Q35363897-ACCE457D-58FB-4DFF-B322-FA0EFBF20E43 Q36984471-542BD0BA-2093-47C5-8803-DCBE6D156DC1 Q37015302-7A5438D2-955A-4D06-8A0B-533F705B7EA1 Q37153640-4DF1DD00-FC3A-496A-9AB9-85A6478C89DA Q39108925-36A094F3-C1E7-42F1-9385-770AAFBC3213 Q39194387-4F61CB2E-87C4-4A64-B8E4-8D81C998C9CF Q45594363-57ECEF10-8029-4F35-AEBC-2DCFBF86FDEC Q47368952-63E7C189-45B3-4964-9163-B38EA7EAA95C Q47823549-4CAECC03-385A-47AB-B402-4209699742D9 Q48261101-A02298FF-3BFA-4D4C-854E-B416FB16DFC1 Q52730181-CA677067-B2C1-4D71-B7D1-2313C8013CE9 Q54976422-3C821FCA-DA19-4733-AF7C-A49617ED3ACC Q55100253-902A5B97-D952-498A-8C51-5F09534FE076

P2860

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

http://www.wikidata.org/entity/Q34293007

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

@ast

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

@en

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

@nl

type

label

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

@ast

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

@en

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

@nl

prefLabel

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

@ast

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

@en

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

@nl

P1433

Q34293007-BFEF1875-BF80-4BED-9A83-1F511FE3FB91

P1476

Q34293007-4952FB57-4628-470F-99BA-490B14C475D6

P2093

Q34293007-10635366-5DD4-4213-8DAB-AD7DCD84909C

Q34293007-203298DA-B9ED-4D03-B29F-12403760BB85

Q34293007-352AB67F-E7D9-4B05-9B18-F0DB526DB969

Q34293007-47F3CE86-CB6E-4ABB-8683-50C7551F469C

Q34293007-4D5F7629-2852-49C5-8AFD-2CEECFCD1839

Q34293007-4DC5D99D-178C-4D8C-89E0-B1B762D03B35

Q34293007-5374AC9C-D05A-4E0C-B76E-0CF3F62548D9

Q34293007-692BE12C-7F5C-4635-A553-441864F67E63

Q34293007-786FD2CC-DE81-4816-9BE1-3C305C3C79E0

Q34293007-813AF6D0-05E7-4BBF-AAD2-CD8E1CAABD38

P2860

Q34293007-028DFF69-5E07-4826-B3C0-12D831B4D476

Q34293007-04F7A814-F439-4102-98BD-F7B7F65637B8

Q34293007-06241284-03A5-4F55-8FAA-3AC999522990

Q34293007-0B3EBC21-2C23-4687-AE4B-4FE0D02A201D

Q34293007-0F6F54FB-49D1-4C6D-ACDB-EFE742E33B61

Q34293007-12C881B9-D83B-4865-8764-ED4DBCE50533

Q34293007-13D61AAF-BC2F-4C2F-84BD-EDCD43E2AA33

Q34293007-15F105A1-3C8C-447F-892B-63B17814F465

Q34293007-18A9C1AE-B86B-422D-A71E-ED2891C68073

Q34293007-1FE0237D-A9D0-4CC7-AC51-FBD449F9645C

P304

Q34293007-C6507655-00CB-4901-B326-D26148059016

P31

Q34293007-897D5BC1-9A81-4DB9-AED4-02A8D6620EDC

P356

Q34293007-F98B6393-5BBF-4B13-A7B7-DEFC0EA5579E

P407

Q34293007-836933AF-6186-480A-BF6C-7E0D856CDBFA

P433

Q34293007-4FD8D5F5-9834-4F2B-BA0F-273E2A46E3CB

P478

Q34293007-DB357CF3-0FAA-4597-BAD4-1F33EFAD576E

P577

Q34293007-341E6C61-B8C4-4089-BE97-A6329D50FF6B

P5875

Q34293007-AB04689D-EC25-4D84-8EAC-A26FBBB5949C

P698

Q34293007-3551D212-E37B-42C3-81C2-3BF0B4E3FFDB

P932

Q34293007-0C675FA5-A910-422D-911D-0CF4B3E50A66

P356

BLOOD-2014-06-584524

P1433

P1476

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

@en

P2093

Alexander Hoellein

http://www.w3.org/2001/XMLSchema#string

Andrei Goga

http://www.w3.org/2001/XMLSchema#string

Christian Peschel

http://www.w3.org/2001/XMLSchema#string

Franz X Schaub

http://www.w3.org/2001/XMLSchema#string

Iina Laitinen

http://www.w3.org/2001/XMLSchema#string

John L Cleveland

http://www.w3.org/2001/XMLSchema#string

Jonas A Nilsson

http://www.w3.org/2001/XMLSchema#string

Lisa Nilsson

http://www.w3.org/2001/XMLSchema#string

Martina Rudelius

http://www.w3.org/2001/XMLSchema#string

Mohammad Fallahi

http://www.w3.org/2001/XMLSchema#string

P2860

A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2

The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.

Sumoylation in gene regulation, human disease, and therapeutic action.

Analysis of C-MYC function in normal cells via conditional gene-targeted mutation

A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis

Probing tumor phenotypes using stable and regulated synthetic microRNA precursors

Second-generation shRNA libraries covering the mouse and human genomes

Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma

MYC on the path to cancer

SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas.

P304

2081-2090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-06-584524

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264940370

http://www.w3.org/2001/XMLSchema#string

P698

25143484

http://www.w3.org/2001/XMLSchema#string

P932

4186537

http://www.w3.org/2001/XMLSchema#string